-
Signature
-
Kaushik Ghoshal, President SaaS Business
-
Stock symbol
-
RMD
-
Transactions as of
-
Aug 12, 2024
-
Transactions value $
-
-$1,201,944
-
Form type
-
4
-
Date filed
-
8/13/2024, 03:51 PM
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$200K |
+2.09K |
+16.01% |
$95.80 |
15.1K |
Aug 12, 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$659K |
+6.88K |
+45.49% |
$95.80 |
22K |
Aug 12, 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$105K |
+1.04K |
+4.71% |
$101.64 |
23K |
Aug 12, 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
-$2.17M |
-10K |
-43.42% |
$216.60 |
13K |
Aug 12, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-2.09K |
-100% |
$0.00* |
0 |
Aug 12, 2024 |
ResMed Common Stock |
2.09K |
$95.80 |
Direct |
F1, F2 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-6.88K |
-100% |
$0.00* |
0 |
Aug 12, 2024 |
ResMed Common Stock |
6.88K |
$95.80 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-1.04K |
-10.07% |
$0.00 |
9.26K |
Aug 12, 2024 |
ResMed Common Stock |
1.04K |
$101.64 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: